Besides, stratified analysis manifested carriers with AURKA gene rs8173 GC/CC were linked to decreased CNS tumor risk in the subgroup of male and clinical stages I + II diseases, with no findings in age and subtypes. Here, AURKA is linked to central nervous system neoplasm.